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INTRODUCTION: Non-steroidal anti-
inflammatory drugs (NSAIDs) are widely used 
for pain control after orthopaedic surgeries. They 
inhibit the enzyme cyclooxygenase (COX), of 
which two isoforms exist (COX-1 and 2). Non-
selective COX inhibitors have been shown to 
delay bone healing, suggesting possible roles of 
COX-1 and COX-2 in bone repair. However the 
distinct functions of COX-1 and COX-2 during 
bone repair and formation are largely unknown. 
This study aims to investigate functions of the 
two enzymes by comparing the effects of 
different COX inhibition in fracture repair, using 
2 well established mouse femoral fracture models 
with different mechanical environments. Further 
investigation using COX-1(-/-) and COX-2(-/-) 
mice is also carried out. 
METHODS: To achieve different COX 
inhibition, mice were treated with ketorolac 
(non-selective COX inhibitor), valdecoxib 
(selective COX-2 inhibitor) or placebo (control). 
Fractures were created on both femora while one 
side was externally-fixed and the other side left 
unfixed. In another set of experiment, the same 
type of fracture surgeries were done in COX-1(-
/-), COX-2(-/-) and wild-type mice (without any 
further treatment). For all the operated mice, 
radiographs were taken weekly. Three time 
points were chosen as 7, 14 and 21 days post-
surgery. Histological analyses and mechanical 
testing were performed. 
RESULTS: In the COX inhibition experiment, 
x-ray showed reduced callus formation in 
ketorolac treated mice, while mechanical testing 
showed significantly decreased stiffness of 
fractured femora from both NSAID groups. 
Histologically, ketorolac showed delayed healing 
in both fixed and unfixed fractures; while 
valdecoxib showed impaired healing in unfixed 
fractures only.  
Interestingly, in COX-2(-/-) mice the impairment 
on bone healing was more severe. Radiographs 
showed reduced callus formation in COX-1(-/-) 
mice at 14 days, and in COX-2(-/-) mice at both 
14 and 21 days. Mechanical testing at 21 day 
showed significantly decreased stiffness of 
fractured femora in COX-2(-/-) mice. Histology 
at 21 day showed severe delay in bone healing of 
unfixed fracture in COX-2(-/-) mice, and minor 
delay in COX-1(-/-) mice. The results of the two 
sets of experiments were summarized in table 1. 
 
Table 1. The effect of COX inhibition (as 
compared to placebo), and the effect of COX 
gene knockout (as compared to wild-type) on 
bone repair 
 Fixed fracture Un-fixed fracture 
 K V A D K V A D 
x-ray / / / / + ─ + ++ 
Histology + ─ ─ ─ + + + ++ 
Mechanical 
testing + + ─ + / / / / 
 
K: ketorolac (both COX-1 and COX-2 
inhibition) 
V: valdecoxib (COX-2 inhibition) 
A: COX-1(-/-) mice 
D: COX-2 (-/-) mice 
+: inhibitory effect (reduced callus formation, 
delay in healing, or reduced mechanical stiffness)  
++: severe inhibitory effect 
─: no effect 
/:  data not available 
 
DISCUSSION & CONCLUSIONS: This is the 
first study to fully investigate the effect of 
various COX inhibition, as well as the effect of 
COX-1 or COX-2 gene deficiency, in both fixed 
and unfixed fracture repair. These results suggest 
that COX-1 and COX-2 are both involved in 
bone healing, yet carrying differential functions. 
COX-1 has minimal function in fixed fracture 
healing and minor function in early stage of 
unfixed fracture healing. COX-2 has minor 
function in fixed fracture healing, but plays an 
essential role throughout unfixed fracture 
healing. As fixed fractures heal predominantly by 
direct bone formation, while unfixed via 
endochondral ossification, this study has 
significant implications on the mechanism of 
bone healing which is the subject of further 
research. 
